Evidence map›Paper›PMID 19929182›Full record

Trial reportScandinavian journal of primary health care2009

Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark.

Lise Juul, Annelli Sandbaek, Anders Foldspang, Morten Frydenberg, Knut Borch-Johnsen, Torsten Lauritzen

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Scandinavian journal of primary health care, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Screening for type 2 diabetes mellitus.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort.The British journal of general practice : the journal of the Royal College of General Practitioners · 2012
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lise JuulDepartment of General Practice, School of Public Health, Aarhus University, Gentofte, Denmark.
Annelli Sandbaek
Anders Foldspang
Morten Frydenberg
Knut Borch-Johnsen
Torsten Lauritzen
Aarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn people with screen-detected type 2 diabetes in primary care, (1) to assess adherence to guidelines, recommending consultation with the GP every three months and treatment initiation with an ACE inhibitor or an angiotensin-II receptor antagonist when systolic BP was > 120 mmHg and/or diastolic BP was > 80 mmHg, and (2) to identify predictors for adherence.

designProspective follow-up of a fixed cohort of patients.

settingFifty-four Danish general practices. SUBJECTS AND

main outcome measuresA total of 361 people with screen-detected type 2 diabetes were followed up for 410 days to assess planned consultations with their GP and recording of BP. Some 226 people, with BP recorded above guideline threshold(s) and where treatment was not already initiated, were followed for up to 410 days to monitor prescription redemption.

resultsAt 3, 6, 9 and 12 months 80%, 77%, 74%, and 73% of the cohort attended a consultation. A total of 89% of the cohort attended two of the four planned consultations. The probability of redeemed prescriptions for an ACE inhibitor or an angiotensin-II receptor antagonist according to the guideline during the first year following diagnosis was 51%. High initial BP was associated with prescription redemption. No other analysed individual or organisational characteristics were found to be associated with treatment initiation.

conclusionThe consultation attendance was reasonably high, and treatment initiation with an ACE inhibitor or an angiotensin-II receptor antagonist according to the guideline was found in half of the cases. High initial BP increased the probability of treatment initiation.

Indexed as

Angiotensin II Type 2 Receptor BlockersAdultAgedAngiotensin-Converting Enzyme InhibitorsBlood Pressure DeterminationDenmarkDiabetes Mellitus, Type 2Family PracticeFemaleFollow-Up StudiesGuideline AdherenceHumansMaleMiddle AgedPatient ComplianceProspective StudiesAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 2 Receptor BlockersReceptor, Angiotensin, Type 2

Identifiers

PMID19929182
PMCPMC3413914
OpenAlexW2103460806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.